Session 6: Global Gene Therapy for Retinal Disease
November 21, 2021
- Describe how clinical trial results differentiate treatments based on functional, anatomic, and visual outcomes
- Evaluate innovative therapies and delivery systems based on their ability to improve durability and maintain visual outcomes
- Identify patients who would be suitable candidates for gene-replacement therapy
This event has concluded.